Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

P. Curry, Michael; G. O’Leary, Jacqueline; Bzowej, Natalie; J. Muir, Andrew; Korenblat, Kevin; M. Fenkel, Jonathan; Rajender Reddy, K.; Lawitz, Eric; L. Flamm, Steven; D. Schiano, Thomas; Teperman, Lewis; J. Fontana, Robert; R. Schiff, Eugene; Fried, Michael; Doehle, Brian; An, Di; McNally, John; Osinusi, Anu; M. Brainard, Diana; G. McHutchison, John; S. Brown, Robert; Charlton, Michael

doi:10.1056/nejmoa1512614

Public

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

Published in New England Journal of Medicine • Nov 16, 2015

Authors:

Michael P. Curry

Jacqueline G. O’Leary

Natalie Bzowej

Abstract

BACKGROUND: As the population that is infected with the hepatitis C virus (HCV) ages, the number of patients with decompensated cirrhosis is expected to increase. METHODS: We conducted a phase 3, open-label study involving both previously treated and previously untreated patients infected with HCV g...

Subject

Medicine

Sofosbuvir

Cirrhosis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!